false
Catalog
Navigating the Complexities of Opioid Use Disorder ...
Presentation Slides
Presentation Slides
Back to course
Pdf Summary
This document is a presentation from an APA (American Psychiatric Association) and SAMHSA (Substance Abuse and Mental Health Services Administration) initiative on the complexities of opioid use disorder (OUD), comorbid psychiatric diagnoses, implications for older adults, and changing DEA (Drug Enforcement Agency) regulations. The presentation aims to provide healthcare professionals with the knowledge and tools needed to address the opioid crisis.<br /><br />The presentation covers several topics, including the most common comorbid psychiatric diagnoses with OUD, the impact of opioid misuse and diversion on the older adult population, and the updated DEA registration and renewal requirements for prescribers of controlled substances.<br /><br />It highlights the higher risk of inadequate or inappropriate care for older adults with severe mental illness (SMI) and the prevalence of major depression in this population. It also discusses the variations in opioid prescriptions among older patients, the physiological changes associated with aging that affect opioid pharmacokinetics, and the safety and use of buprenorphine for older adults with OUD.<br /><br />The presentation emphasizes the recent changes in legislation, such as the mainstreaming addiction treatment (MAT) act and the medication access and training expansion (MATE) act, which have increased the number of potential prescribers for OUD and outlined new training requirements for buprenorphine prescribers.<br /><br />In conclusion, while there is limited data on the aging population with opioid use or misuse, older adults receiving treatment for OUD respond well to treatment. It is important for healthcare professionals to stay updated on evidence-based medications for OUD treatment and to consider prevention strategies and safe opioid prescribing practices for older adults with problematic opioid use.
Keywords
opioid use disorder
comorbid psychiatric diagnoses
older adults
DEA regulations
healthcare professionals
opioid crisis
opioid misuse
buprenorphine
severe mental illness
safe opioid prescribing practices
Funding for SMI Adviser was made possible by Grant No. SM080818 from SAMHSA of the U.S. Department of Health and Human Services (HHS). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, SAMHSA/HHS or the U.S. Government.
×
Please select your language
1
English